- Exenatide +12006 | Second Faculty of Medicine
- Exenatide QW +12012 | Second Faculty of Medicine
- Prolonged-relase exenatide in the treatment of diabetes - possibility of once-weekly administration2014 | First Faculty of Medicine
- Exenatide +12008 | First Faculty of Medicine
- Exenatid and its position as antidiabetic drug in the treatment of type 2 diabetes mellitus2008 | Second Faculty of Medicine
- Efficacy and safety of exenatide once daily added to maximal dose of sitagliptine and pioglitazone2011 | First Faculty of Medicine
- The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters2010 | First Faculty of Medicine
- Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic – BIBY-I study (observations lasting 3 to 12 months)2013 | Second Faculty of Medicine
- Case reports of patients from the study BIBY or how does exenatide work in patients with type 2 diabetes mellitus2013 | Second Faculty of Medicine
- Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)2013 | Central Library of Charles University
- Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic – BIBY-II study (observations lasting 24 months)2013 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-II study (observations lasting 24 months)2013 | Central Library of Charles University
- Exenatid ER v kombinované léčbě diabetes mellitus 2. typu2017 | First Faculty of Medicine
- New drugs in type 2 diabetes mellitus therapy2013 | Second Faculty of Medicine
- Incretin hormones and the role of incretin mimetics in the treatment of type 2 diabetes mellitus2006 | Second Faculty of Medicine
- Glucagon-Like Peptide-1 Analogues Exenatide and Liraglutide Exert Inhibitory Effect on the Early Phase of Liver Regeneration After Partial Hepatectomy in Rats2017 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Effect of continuous exenatide infusion on cardiac function and peri-operative glucose control in patients undergoing cardiac surgery: A single-blind, randomized controlled trial2017 | First Faculty of Medicine
- Efficacy and safety of exenatide as add-on therapy for patients with type 2 diabetes with an intensive insulin regimen : A randomized double-blind trial2021 | Faculty of Medicine in Pilsen
- Continuous exenatide infusion improved perioperative glucose control and reduced glycaemic variability in cardiac surgery patients: the EXECUTIVE trial +1Publication without faculty affiliation
- How will diabetes treatment change with new pharmaceuticals?2015 | Second Faculty of Medicine
- Inkretinová analoga2018 | First Faculty of Medicine
- Liraglutid demonstrated the effect of weight reduction2008 | Second Faculty of Medicine
- Komentář ke studii (Uspořádání a výchozí charakteristiky účastníků kardiovaskulární studie REWIND s dulaglutidem)2018 | First Faculty of Medicine
- Pharmacological and non-pharmacological options for modifying the body weight in diabetic patients2010 | First Faculty of Medicine
- Recent advances in the treatment of diabetes mellitus - what is available and what is foreseeable2007 | Second Faculty of Medicine
- Therapy based on the incretin effect2009 | Second Faculty of Medicine